Amicus Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	528.3	399.36	329.23	305.51	260.89	Upgrade
Revenue Growth (YoY)	32.29%	21.30%	7.76%	17.11%	43.16%	Upgrade
Cost of Revenue	52.94	37.33	38.6	34.47	31.04	Upgrade
Gross Profit	475.35	362.03	290.63	271.05	229.84	Upgrade
Selling, General & Admin	323.38	275.27	213.04	192.71	156.41	Upgrade
Research & Development	109.36	152.38	276.68	272.05	308.44	Upgrade
Operating Expenses	441.29	435.52	495.06	470.97	473.7	Upgrade
Operating Income	34.06	-73.49	-204.43	-199.92	-243.85	Upgrade
Interest Expense	-49.6	-50.15	-37.12	-32.47	-22.43	Upgrade
Interest & Investment Income	5.41	7.08	3.02	0.51	3.23	Upgrade
Other Non Operating Income (Expenses)	-9.44	-15.89	4.18	-2.9	-0.78	Upgrade
EBT Excluding Unusual Items	-19.57	-132.45	-234.35	-234.78	-263.83	Upgrade
Merger & Restructuring Charges	-9.19	-	-	-	-	Upgrade
Asset Writedown	-	-1.13	-6.62	-	-	Upgrade
Other Unusual Items	-	-16.52	-1.08	-6.77	-10.42	Upgrade
Pretax Income	-28.76	-150.1	-242.04	-241.55	-274.25	Upgrade
Income Tax Expense	27.35	1.48	-5.47	8.91	2.6	Upgrade
Net Income	-56.11	-151.58	-236.57	-250.46	-276.85	Upgrade
Net Income to Common	-56.11	-151.58	-236.57	-250.46	-276.85	Upgrade
Shares Outstanding (Basic)	304	295	289	271	259	Upgrade
Shares Outstanding (Diluted)	304	295	289	271	259	Upgrade
Shares Change (YoY)	3.12%	2.11%	6.50%	4.85%	7.67%	Upgrade
EPS (Basic)	-0.18	-0.51	-0.82	-0.92	-1.07	Upgrade
EPS (Diluted)	-0.18	-0.51	-0.82	-0.92	-1.07	Upgrade
Free Cash Flow	-37.44	-76.53	-170.34	-206.38	-236.52	Upgrade
Free Cash Flow Per Share	-0.12	-0.26	-0.59	-0.76	-0.91	Upgrade
Gross Margin	89.98%	90.65%	88.28%	88.72%	88.10%	Upgrade
Operating Margin	6.45%	-18.40%	-62.09%	-65.44%	-93.47%	Upgrade
Profit Margin	-10.62%	-37.96%	-71.85%	-81.98%	-106.12%	Upgrade
Free Cash Flow Margin	-7.09%	-19.16%	-51.74%	-67.55%	-90.66%	Upgrade
EBITDA	42.61	-65.62	-199.08	-193.71	-235.01	Upgrade
EBITDA Margin	8.07%	-16.43%	-60.47%	-63.41%	-90.08%	Upgrade
D&A For EBITDA	8.55	7.87	5.34	6.21	8.85	Upgrade
EBIT	34.06	-73.49	-204.43	-199.92	-243.85	Upgrade
EBIT Margin	6.45%	-18.40%	-62.09%	-65.44%	-93.47%	Upgrade

Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q